(VELA) Study of BLU-222 in Advanced Solid Tumors
Blueprint Medicines Corporation
Blueprint Medicines Corporation
OHSU Knight Cancer Institute
Emory University
City of Hope Medical Center
GOG Foundation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
AGO Study Group
National Institutes of Health Clinical Center (CC)
NYU Langone Health